{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T10:45:07Z","timestamp":1767869107009,"version":"3.49.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","funder":[{"name":"Coordination for the Improvement of Higher Education Personnel\u2014Brazil","award":["001"],"award-info":[{"award-number":["001"]}]},{"DOI":"10.13039\/spbyzxgof3aq","name":"Pr\u00f3-Reitoria de Pesquisa e Inova\u00e7\u00e3o - Universidade de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["246806\/2024"],"award-info":[{"award-number":["246806\/2024"]}],"id":[{"id":"10.13039\/spbyzxgof3aq","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Despite the general recommendation of AUC\n                      <jats:sub>0\u201324h<\/jats:sub>\n                      \/MIC ratio of 400\u2013600 mg\u00b7h\/L for vancomycin (VAN) effectiveness, there is no strong evidence of this index for patients undergoing renal replacement therapy (RRT). The aim of this scoping review was to summarize the scientific literature to assess the current evidence on VAN monitoring in hospitalized patients receiving intermittent hemodialysis (HD), identify gaps in knowledge, and guide future research.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic search was performed using PubMed, Web of Science, Embase, LILACS, and the Cochrane Library databases based on keywords related to VAN, dialysis, and Therapeutic Drug Monitoring (TDM). References in the articles were also screened. The inclusion criteria were studies involving hospitalized adults undergoing intermittent HD, receiving intravenous VAN therapy, and with available TDM data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Systematic searches retrieved 297 articles, of which 21 were selected along with 1 from the reference screening, for 22 included studies. Clinical outcome data are still insufficient to determine the best VAN TDM parameters for patients undergoing intermittent HD. Target attainment was suboptimal in most settings regardless of the TDM method. The intradialytic removal of VAN is highly variable because of the combination of the RRT modality, RRT parameters, and dialyzer characteristics, which are often poorly described. The exact influence of the RRT parameters on intermittent RRT settings remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The poor description of RRT, suboptimal VAN target attainment, and limited clinical outcome data in patients undergoing intermittent HD highlight the urgent need for further research. As VAN removal during RRT is influenced by a complex interplay of factors, improved dosing and monitoring strategies are required. In the future, model-informed precision dosing may play a significant role in optimizing VAN therapy in patients undergoing intermittent HD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001368","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T18:01:42Z","timestamp":1755194502000},"page":"80-90","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A Scoping Review on Vancomycin Monitoring in Intermittent Hemodialysis: Current Evidence and Future Perspectives"],"prefix":"10.1097","volume":"48","author":[{"given":"Nath\u00e1lia Rodrigues","family":"Corr\u00eaa","sequence":"first","affiliation":[{"name":"Department of Pharmacy, School of Pharmaceutical Sciences, University of S\u00e3o Paulo, S\u00e3o Paulo, S\u00e3o Paulo, Brazil;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Kaneko","family":"Matsuno","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Pharmaceutical Sciences, University of S\u00e3o Paulo, S\u00e3o Paulo, S\u00e3o Paulo, Brazil;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronaldo","family":"Morales Junior","sequence":"additional","affiliation":[{"name":"Division of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayra Carvalho","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"Clinical Hospital, University of Campinas, Campinas, S\u00e3o Paulo, Brazil; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00e1cio de Mendon\u00e7a","family":"Lima","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Pharmaceutical Administration, Faculty of Pharmacy, Fluminense Federal University, Niter\u00f3i, Rio de Janeiro, Brazil."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00edlia Berlofa","family":"Visacri","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Pharmaceutical Sciences, University of S\u00e3o Paulo, S\u00e3o Paulo, S\u00e3o Paulo, Brazil;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6986-6193","authenticated-orcid":false,"given":"Jhohann Richard de Lima","family":"Benzi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Pharmaceutical Sciences, University of S\u00e3o Paulo, S\u00e3o Paulo, S\u00e3o Paulo, Brazil;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"R1-20260108","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0025-6196(12)65799-1","article-title":"Vancomycin","volume":"66","author":"Wilhelm","year":"1991","journal-title":"Mayo Clin Proc."},{"key":"R2-20260108","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.34067\/KID.0000192021","article-title":"New vancomycin dosing guidelines for hemodialysis patients: rationale, caveats, and limitations","volume":"2","author":"Lewis","year":"2021","journal-title":"Kidney360"},{"key":"R3-20260108","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American society of health-system pharmacists, the infectious diseases society of America, and the society of infectious diseases pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm."},{"key":"R4-20260108","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","article-title":"Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American society of health-system pharmacists, the infectious diseases society of America, the pediatric infectious diseases society, and the society of infectious diseases pharmacists","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm."},{"key":"R5-20260108","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1525-139X.2010.00803.x","article-title":"Vancomycin dosing in patients on intermittent hemodialysis","volume":"24","author":"Vandecasteele","year":"2011","journal-title":"Semin Dial."},{"key":"R6-20260108","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med."},{"key":"R7-20260108","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and Mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev."},{"key":"R8-20260108","first-page":"179","article-title":"Vancomycin therapy for serious staphylococcal infections in chronic hemodialysis patients","volume":"4","author":"Bierman","year":"1980","journal-title":"J Dial."},{"key":"R9-20260108","first-page":"607","article-title":"Dosificaci\u00f3n de vancomicina en pacientes en hemodi\u00e1lisis","volume":"28","author":"Castellano","year":"2008","journal-title":"Nefrologia"},{"key":"R10-20260108","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1413-8670(10)70041-6","article-title":"Vancomycin: the need to suit serum concentrations in hemodialysis patients","volume":"14","author":"Marengo","year":"2010","journal-title":"Braz J Infect Dis."},{"key":"R11-20260108","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/cid\/cis458","article-title":"Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis","volume":"55","author":"Zelenitsky","year":"2012","journal-title":"Clin Infect Dis."},{"key":"R12-20260108","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000453005","article-title":"Vancomycin during the last hour of the hemodialysis session: a pharmacokinetic analysis","volume":"135","author":"Ghouti-Terki","year":"2017","journal-title":"Nephron"},{"key":"R13-20260108","doi-asserted-by":"crossref","first-page":"198","DOI":"10.5414\/CN109091","article-title":"Optimization of therapeutic drug monitoring of vancomycin in patients with chronic hemodialysis","volume":"88","author":"Mahmoud","year":"2017","journal-title":"Clin Nephrol."},{"key":"R14-20260108","doi-asserted-by":"crossref","first-page":"112","DOI":"10.15171\/jrip.2019.21","article-title":"Vancomycin dosing in low-flux hemodialysis; is adjustment of drug dosage necessary?","volume":"8","author":"Khodabandehloo","year":"2018","journal-title":"J Ren Inj Prev"},{"key":"R15-20260108","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/FTD.0000000000000920","article-title":"Optimal sampling strategy and threshold of serum vancomycin concentration in elderly Japanese patients undergoing high-flux hemodialysis","volume":"44","author":"Ogawa","year":"2022","journal-title":"Ther Drug Monit."},{"key":"R16-20260108","doi-asserted-by":"crossref","first-page":"8","DOI":"10.53350\/pjmhs020241862","article-title":"Therapeutic drug monitoring (TDM) based precise doing of vancomycin in intermittent hemodialysis (IHD) patients","volume":"18","author":"Saeed","year":"2024","journal-title":"Pakistan J Med Health Sci."},{"key":"R17-20260108","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1186\/s12879-024-08984-z","article-title":"Impact of vancomycin trough levels monitoring on uncomplicated methilcillin-resistant Staphylococcus aureus bacteremia in chronic kidney disease on hemodialysis, retrospective cohort","volume":"24","author":"Ramirez-Osorio","year":"2024","journal-title":"BMC Infect Dis."},{"key":"R18-20260108","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/039139889401700104","article-title":"Vancomycin dosing in haemodialysis patients and Bayesian estimate of individual pharmacokinetic parameters","volume":"17","author":"Keller","year":"1994","journal-title":"Int J Artif Organs"},{"key":"R19-20260108","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1130-6343(05)73695-3","article-title":"Monitorizaci\u00f3n de las concentraciones plasm\u00e1ticas de vancomicina en pacientes en hemodi\u00e1lisis","volume":"29","author":"Ruano","year":"2005","journal-title":"Farmacia Hospitalaria"},{"key":"R20-20260108","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1080\/0886022X.2016.1229992","article-title":"Evaluation of weight-based vancomycin dosing for hospitalized hemodialysis patients","volume":"38","author":"Maxson","year":"2016","journal-title":"Ren Fail."},{"key":"R21-20260108","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4212\/cjhp.v72i5.2930","article-title":"Validation of a weight threshold-based vancomycin dosing protocol for patients undergoing intermittent hemodialysis","volume":"72","author":"Sun","year":"2019","journal-title":"Can J Hosp Pharm."},{"key":"R22-20260108","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/nep.14144","article-title":"Vancomycin use for haemodialysis patients-Development of a new dosing protocol","volume":"28","author":"Ho","year":"2023","journal-title":"Nephrology (Carlton)."},{"key":"R23-20260108","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/ndt\/4.7.635","article-title":"Pharmacokinetics of vancomycin in patients undergoing haemodialysis and haemofiltration","volume":"4","author":"De Bock","year":"1989","journal-title":"Nephrol Dial Transpl."},{"key":"R24-20260108","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1681\/ASN.V641284","article-title":"Influence of cellulose triacetate hemodialyzers on vancomycin pharmacokinetics","volume":"6","author":"Welage","year":"1995","journal-title":"J Am Soc Nephrol."},{"key":"R25-20260108","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000170237","article-title":"Effects of slowly performed daytime hemodialysis (slow HD) on the pharmacokinetics of vancomycin in hemodynamically unstable patients with renal failure","volume":"14","author":"Kihara","year":"1996","journal-title":"Blood Purif."},{"key":"R26-20260108","doi-asserted-by":"crossref","first-page":"342","DOI":"10.5507\/bp.2012.002","article-title":"Vancomycin removal during low-flux and high-flux extended daily hemodialysis in critically ill septic patients","volume":"156","author":"Petejova","year":"2012","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"R27-20260108","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/1120009X.2021.1979747","article-title":"Vancomycin pharmacokinetics in patients treated with intermittent haemodialysis based on therapeutic drug monitoring","volume":"34","author":"Hartinger","year":"2022","journal-title":"J Chemother."},{"key":"R28-20260108","doi-asserted-by":"crossref","first-page":"484","DOI":"10.22146\/ijp.4433","article-title":"Evaluation of trough-based vancomycin therapy in achieving targeted area under the curve in haemodialysis cases","volume":"33","author":"Keshavarzi","year":"2022","journal-title":"Indonesian J Pharm."},{"key":"R29-20260108","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/FTD.0000000000001065","article-title":"Population pharmacokinetics of vancomycin in patients receiving hemodialysis in a Malian and a French center and simulation of the optimal loading dose","volume":"45","author":"Coulibaly","year":"2023","journal-title":"Ther Drug Monit."},{"key":"R30-20260108","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1055\/s-0042-1742346","article-title":"Hemodialysis catheters: update on types, outcomes, designs and complications","volume":"39","author":"El Khudari","year":"2022","journal-title":"Semin Intervent Radiol."},{"key":"R31-20260108","doi-asserted-by":"crossref","first-page":"e0193585","DOI":"10.1371\/journal.pone.0193585","article-title":"The ratio of pre-dialysis vancomycin trough serum concentration to minimum inhibitory concentration is associated with treatment outcomes in methicillin-resistant Staphylococcus aureus bacteremia","volume":"13","author":"Fu","year":"2018","journal-title":"PLoS One"},{"key":"R32-20260108","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/ki.1994.28","article-title":"Vancomycin redistribution: dosing recommendations following high-flux hemodialysis","volume":"45","author":"Pollard","year":"1994","journal-title":"Kidney Int."},{"key":"R33-20260108","first-page":"434","article-title":"Acute kidney injury and renal replacement therapy: terminology standardization","volume":"44","author":"Reis","year":"2022","journal-title":"J Bras Nefrol"},{"key":"R34-20260108","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/bcp.13904","article-title":"Predicting the dose of vancomycin in ICU patients receiving different types of RRT therapy: a model\u2010based meta\u2010analytic approach","volume":"85","author":"Claisse","year":"2019","journal-title":"Br J Clin Pharmacol."},{"key":"R35-20260108","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/sdi.12926","article-title":"Evaluating dialysis adequacy: origins, evolution, and future directions","volume":"33","author":"Momciu","year":"2020","journal-title":"Semin Dial."},{"key":"R36-20260108","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.2215\/CJN.02660221","article-title":"Classification of uremic toxins and their role in kidney failure","volume":"16","author":"Rosner","year":"2021","journal-title":"Clin J Am Soc Nephrol."},{"key":"R37-20260108","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1093\/ajhp\/52.24.2794","article-title":"New hemodialysis membranes and vancomycin clearance","volume":"52","author":"Meyer","year":"1995","journal-title":"Am J Health Syst Pharm."},{"issue":"suppl 1","key":"R38-20260108","first-page":"i36","article-title":"Dialysis membrane: from convection to adsorption","volume":"3","author":"Santoro","year":"2010","journal-title":"NDT Plus"},{"key":"R39-20260108","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0272-6386(12)70298-6","article-title":"Vancomycin elimination during high-flux hemodialysis: kinetic model and comparison of four membranes","volume":"20","author":"DeSoi","year":"1992","journal-title":"Am J Kidney Dis."},{"key":"R40-20260108","first-page":"M375","article-title":"The effect of ultrafiltration on dialysance. Mathematical theory and experimental verification","volume":"37","author":"Hootkins","year":"1991","journal-title":"ASAIO Trans."},{"key":"R41-20260108","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/aor.13368","article-title":"Vancomycin hemodialysis: clearance differences between high-flux hemodialysis and on-line hemodiafiltration","volume":"43","author":"Rodr\u00edguez","year":"2019","journal-title":"Artif Organs"},{"key":"R42-20260108","doi-asserted-by":"crossref","first-page":"e0199158","DOI":"10.1371\/journal.pone.0199158","article-title":"Factors affecting serum concentration of vancomycin in critically ill oliguric pediatric patients receiving continuous venovenous hemodiafiltration","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One"},{"key":"R43-20260108","doi-asserted-by":"crossref","first-page":"6861","DOI":"10.3390\/ijerph17186861","article-title":"Vancomycin for dialytic therapy in critically ill patients: analysis of its reduction and the factors associated with subtherapeutic concentrations","volume":"17","author":"Freitas","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"R44-20260108","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.2215\/CJN.03450410","article-title":"Vancomycin pharmacokinetics and pharmacodynamics during short daily hemodialysis","volume":"5","author":"Decker","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"key":"R45-20260108","doi-asserted-by":"crossref","first-page":"e0008923","DOI":"10.1128\/aac.00089-23","article-title":"Model-informed precision dosing of vancomycin in adult patients undergoing hemodialysis","volume":"67","author":"Oda","year":"2023","journal-title":"Antimicrob Agents Chemother."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:01:33Z","timestamp":1767848493000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001368","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"2025-01-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}